Articles related to WOMEN'S HEALTH

This retrospective cohort study provides a detailed analysis of overdiagnosis in breast cancer screening among women aged 70 and above. Physicians are encouraged to explore the findings to better understand the implications of screening practices for older women.

Dr. Susan Love, a revered figure in the realm of oncology, has left a legacy of patient advocacy and innovative research, driving physicians to approach patient care and cancer research with empathy, courage, and forward-thinking dynamism.

As the FDA approves the first over-the-counter oral contraceptive, dental professionals must be cognizant of potential impacts on oral health and patient management.

Emerging research uncovers potential associations between the use of menopausal hormone therapy and an increased risk of dementia, including Alzheimer’s disease. Discover more about the implications of these findings for women’s health management.

Marlene P. Freeman, MD, is an expert in women’s reproductive mental health, the editor-in-chief of The Journal of Clinical Psychiatry, and a professor of psychiatry at Harvard Medical School. She provides ideas that are clinically applicable in this 5 Minute Pearls video. As physicians, understanding the nuances of postpartum psychiatric disorders is crucial for effective patient care. Here are the key takeaways from Dr. Freeman’s insights:

Dr. Jyoti Mayadev, a professor of Radiation Medicine at University of California San Diego, discussed the treatment of patients with 1B3 cervical cancer at the Society of Gynecological Oncology’s Annual Meeting on Women’s Cancer. The discussion centered around whether to treat patients with primary chemoradiation and brachytherapy or radical surgery. Dr. Mayadev recommends a multidisciplinary approach, but notes that level 1 evidence data from Landoni et al. in 1997 showed no difference in progression-free survivals or overall survivals between radiation therapy and radical hysterectomy in patients with bulky disease, 1B3, and no lymph node disease. Dr. Mayadev discusses the benefits of chemoradiation, including potential toxicity reduction if a patient needs adjuvant therapy after surgery. She also notes that with technologically advanced radiation and brachytherapy, long-term toxicities can be minimized, including genitourinary toxicities at 6-8%, vaginal toxicities at 5%, and fistula at less than 2%. Dr. Mayadev believes that adaptive radiation therapy may further decrease toxicities and increase cure rates for patients with 1B3 cervical cancer. There are ongoing trials for novel therapeutics and adaptive radiation therapy, such as the ARTIA Cervical Trial, which aims to decrease toxicities and collect patient reported outcomes.